Studies have shown that L-733,060 and the aprepitant drug increase the occurrence of apoptotic DNA features, leading to the cleavage of caspase-3 and poly (ADP-ribose) polymerase in hepatoblastoma and glioma cell lines [12,44]. The gene discussed is CASP3; the disease is central nervous system cancer.